Clinical Trials Logo

Clinical Trial Summary

This is an open-label, multiple center, parallel-group Study to compare the pharmacokinetics and safety of single-dose benapenem (1.0mg) in subjects with mild or moderate Renal Impairment(RI) and healthy subjects. Subjects were enrolled with defined degrees of RI based on eGFR(estimated Glomerular Filtration Rate) calculated by MDRD (Modification of Diet in Renal Disease)formular as follows: nomal renal function(≥90ml/min/1.73m2 ; N=6); mild RI (60-89mL/min/1.73 m2 ; N=6), moderate RI (30-59 mL/min/1.73m2 ; N=6)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04476407
Study type Interventional
Source Sihuan Pharmaceutical Holdings Group Ltd.
Contact
Status Completed
Phase Phase 1
Start date June 15, 2019
Completion date October 21, 2019